Press & Statements Archives

S&P Report Finds Rx Prices Driving Increased Health Care Costs

May 10, 2016

"Annual prescription price hikes are driving the overall increase in health care costs and making health care less affordable for Americans. Today's S&P report confirms what we've been saying — these increases in drug cost are unsustainable — and solutions to promote transparency, increase competition, and focus on value must be advanced," said John Rother, executive director of the Campaign for Sustainable Rx Pricing (CSRxP). Read More

Quick Facts About Rising Prescription Drug Costs

Apr 25, 2016

Drug prices in the United States are too high and continue to skyrocket. The unsustainable cost of prescription drugs not only puts pressure on the health care system but increasingly; patients, employers, and providers are paying prices that are too high. Read More

Proposals for Change: Transparency, Competition and Value

Apr 25, 2016

Drug prices in the United States are too high and sharply rising prescription drug prices threaten the affordability of health care and the vitality of our entire economy. CSRxP has developed market-based reforms that restore a functioning market by increasing transparency, promoting competition and innovation, and that result in value. Read More

CSRxP to Unveil Market-Based Solutions to Address Soaring Drug Prices

Apr 20, 2016

The Campaign for Sustainable Rx Pricing (CSRxP) will release market-based policy solutions to curb rising drug prices at a discussion at the Newseum in Washington, DC on Monday, April 25th at 10:00 a.m. Read More

Walmart Joins Campaign for Sustainable Rx Pricing

Apr 19, 2016

“It’s important to Walmart to help find solutions to health care costs that continue to rise for individuals and the companies that insure them. With more than 1.1 million associates and family members on Walmart’s health care plans and millions of customers that visit pharmacies in our stores and clubs each week, we understand the importance of quality, affordable health care," said Sally Welborn, senior vice president of global benefits at Walmart. Read More

Nurse Anesthetists Sign on to Campaign for Sustainable Rx Pricing

Apr 14, 2016

Today the National Coalition on Health Care Action Fund announced that the American Association of Nurse Anesthetists (AANA) has joined the coalition’s Campaign for Sustainable Rx Pricing which works to find market-based solutions to rising prescription drug prices. Read More

John Rother Statement on IMS Health Report

Apr 14, 2016

“Excessive price hikes on prescription drugs drive up spending year after year with no end in sight. Drug makers' annual habit of demanding a blank check, without reference to any change in value from patients and taxpayers, makes it harder for American families to make ends meet. Ultimately, these price increases make health care more expensive for all of us, even those who don’t use prescription drugs. It’s outrageous.” Read More

John Rother Statement on Reuters Analysis of Prescription Drug Price Increases

Apr 4, 2016

“This is further evidence that skyrocketing drug prices are more widespread than a few bad actors. When major drug companies hike prices on common prescription drugs, Americans suffer. Families are forced to decide between paying for prescriptions or paying bills, and that’s wrong.” Read More

American Academy of Neurology Joins Campaign for Sustainable Rx Pricing

Mar 29, 2016

Today the National Coalition on Health Care Action Fund announced that the American Academy of Neurology (AAN) has officially joined the coalition’s Campaign for Sustainable Rx Pricing. The American Academy of Neurology represents 30,000 members and is dedicated to promoting the highest quality patient-centered neurologic care. Read More

Senate Special Committee on Aging Examines Drug Pricing

Mar 17, 2016

"Companies are buying decades-old prescription drugs and jacking up prices on vulnerable patients. It’s unconscionable. We need more transparency and competition in the prescription drug market to protect Americans from this appalling practice.” Read More

FDA to Prioritize Generic Drug Applications

Mar 15, 2016

"Recently, the FDA took an important first step in acknowledging the need to introduce more competition by prioritizing generic applications where there is no competition. This effort will give patients better access to affordable treatments," said John Rother, executive director of the Campaign for Sustainable Rx Pricing. Read More

AARP Joins Campaign for Sustainable Rx Pricing

Mar 3, 2016

Today the National Coalition of Health Care announced that AARP has officially joined the coalition’s Campaign for Sustainable Rx Pricing. AARP is a nonprofit, nonpartisan organization, with a membership of nearly 38 million Americans and shares the Campaign’s goal of finding market-based solutions to reverse the trend of high and rising prescription drug prices. Read More